UAMY vs. INVA

Last updated Jun 5, 2026

UAMY (United States Antimony Corporation) and INVA (Innoviva, Inc.) are both stocks. UAMY operates in Other Industrial Metals & Mining (Basic Materials), while INVA operates in Biotechnology (Healthcare). Over the past 10 years, UAMY returned 42.36%/yr vs 6.84%/yr for INVA. At a 0.06 correlation, their price movements are largely independent.

Performance

UAMY vs. INVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United States Antimony Corporation (UAMY) and Innoviva, Inc. (INVA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UAMY achieves a 72.31% return, which is significantly higher than INVA's 10.86% return. Over the past 10 years, UAMY has outperformed INVA with an annualized return of 42.36%, while INVA has yielded a comparatively lower 6.84% annualized return.

UAMY

• 1D: -5.57%
• 1M: -22.42%
• YTD: 72.31%
• 6M: 41.34%
• 1Y: 214.55%
• 3Y*: 197.08%
• 5Y*: 55.26%
• 10Y*: 42.36%

INVA

• 1D: 2.12%
• 1M: -2.16%
• YTD: 10.86%
• 6M: 6.54%
• 1Y: 6.13%
• 3Y*: 18.85%
• 5Y*: 11.29%
• 10Y*: 6.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UAMY vs. INVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UAMY United States Antimony Corporation	72.31%	183.62%	610.84%	-48.86%	-2.19%	-4.64%	35.58%	-33.62%	81.25%	27.49%
INVA Innoviva, Inc.	10.86%	15.22%	8.17%	21.06%	-23.19%	39.23%	-12.50%	-18.85%	22.97%	32.62%

Correlation

The correlation between UAMY and INVA is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (10Y) Calculated over the trailing 10-year period	0.10
Correlation (All Time) Calculated using the full available price history since Oct 6, 2004	0.06

Fundamentals

Market Cap UAMY : $1.22B INVA : $1.88B
EPS UAMY : -$0.13 INVA : $5.94
PS Ratio UAMY : 28.57 INVA : 4.44
PB Ratio UAMY : 9.29 INVA : 1.30
Total Revenue (TTM) UAMY : $39.04M INVA : $424.12M
Gross Profit (TTM) UAMY : $4.34M INVA : $323.16M
EBITDA (TTM) UAMY : -$15.23M INVA : $438.91M

Return for Risk

UAMY vs. INVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UAMY

UAMY Risk / Return Rank: 80
UAMY Sharpe Ratio Rank: 84
UAMY Sortino Ratio Rank: 83
UAMY Omega Ratio Rank: 78
UAMY Calmar Ratio Rank: 82
UAMY Martin Ratio Rank: 76

INVA

INVA Risk / Return Rank: 47
INVA Sharpe Ratio Rank: 49
INVA Sortino Ratio Rank: 45
INVA Omega Ratio Rank: 42
INVA Calmar Ratio Rank: 48
INVA Martin Ratio Rank: 49

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UAMY vs. INVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United States Antimony Corporation (UAMY) and Innoviva, Inc. (INVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UAMY	INVA	Difference
Sharpe ratio: Return per unit of total volatility	1.63	0.21	+1.42
Sortino ratio: Return per unit of downside risk	2.56	0.60	+1.96
Omega ratio: Gain probability vs. loss probability	1.28	1.07	+0.22
Calmar ratio: Return relative to maximum drawdown	2.91	0.26	+2.65
Martin ratio: Return relative to average drawdown	5.06	0.60	+4.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UAMY vs. INVA - Sharpe Ratio Comparison

The current UAMY Sharpe Ratio is 1.63, which is higher than the INVA Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of UAMY and INVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UAMY	INVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.63	0.21	+1.42
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.59	0.42	+0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.42	0.20	+0.22
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.05	+0.02

Drawdowns

UAMY vs. INVA - Drawdown Comparison

The maximum UAMY drawdown since its inception was -96.44%, which is greater than INVA's maximum drawdown of -84.32%. Use the drawdown chart below to compare losses from any high point for UAMY and INVA.

Drawdown Indicators

	UAMY	INVA	Difference
Max Drawdown Largest peak-to-trough decline	-96.44%	-84.32%	-12.12%
Max Drawdown (1Y) Largest decline over 1 year	-74.30%	-23.53%	-50.77%
Max Drawdown (3Y) Largest decline over 3 years	-74.30%	-23.53%	-50.77%
Max Drawdown (5Y) Largest decline over 5 years	-80.46%	-47.01%	-33.45%
Max Drawdown (10Y) Largest decline over 10 years	-89.76%	-59.57%	-30.19%
Current Drawdown Current decline from peak	-50.49%	-30.71%	-19.78%
Average Drawdown Average peak-to-trough decline	-66.42%	-44.66%	-21.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	42.63%	10.18%	+32.45%

Volatility

UAMY vs. INVA - Volatility Comparison

United States Antimony Corporation (UAMY) has a higher volatility of 32.56% compared to Innoviva, Inc. (INVA) at 7.52%. This indicates that UAMY's price experiences larger fluctuations and is considered to be riskier than INVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UAMY	INVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.56%	7.52%	+25.04%
Volatility (6M) Calculated over the trailing 6-month period	92.98%	16.83%	+76.15%
Volatility (1Y) Calculated over the trailing 1-year period	132.20%	28.82%	+103.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	94.87%	27.29%	+67.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	101.03%	33.88%	+67.15%

Dividends

UAMY vs. INVA - Dividend Comparison

Neither UAMY nor INVA has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
INVA Innoviva, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.12%
UAMY United States Antimony Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both UAMY and INVA in my portfolio?

UAMY and INVA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UAMY or INVA?

UAMY has higher volatility (32.56%) compared to INVA (7.52%). In terms of maximum drawdown, UAMY dropped -96.44% vs INVA's -84.32%.

Which has better risk-adjusted returns?

UAMY currently has the higher Sharpe Ratio (1.63 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.